76 related articles for article (PubMed ID: 34568316)
1. TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts.
White SE; Schwartze TA; Mukundan A; Schoenherr C; Singh SP; van Dinther M; Cunningham KT; White MPJ; Campion T; Pritchard J; Hinck CS; Ten Dijke P; Inman G; Maizels RM; Hinck AP
bioRxiv; 2023 Dec; ():. PubMed ID: 38187573
[TBL] [Abstract][Full Text] [Related]
2. A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling.
Petersen SH; Al Badawy K; Hopkins R; Vu DL; Rahmani M; Maia SMP; Connolly JE
Mol Ther Oncolytics; 2023 Dec; 31():100730. PubMed ID: 37829123
[TBL] [Abstract][Full Text] [Related]
3. Directed Blocking of TGF-β Receptor I Binding Site Using Tailored Peptide Segments to Inhibit its Signaling Pathway.
Sepehri S; Arab SS; Behmanesh M; H Sajedi R
Iran J Biotechnol; 2020 Jan; 18(1):e2561. PubMed ID: 32884960
[TBL] [Abstract][Full Text] [Related]
4. STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations.
Mohammed OA; Abdel-Reheim MA; Alamri MMS; Alfaifi J; Adam MIE; Saleh LA; Farrag AA; Yahia AIO; Abdel-Ghany S; AlQahtani AAJ; Bahashwan E; Eltahir HB; Mohammed NA; El-Wakeel HS; Hazem SH; Saber S
Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630994
[TBL] [Abstract][Full Text] [Related]
5. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation.
Messner CJ; Schmidt S; Özkul D; Gaiser C; Terracciano L; Krähenbühl S; Suter-Dick L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575957
[TBL] [Abstract][Full Text] [Related]
6.
Beauchamp EM; Leventhal M; Bernard E; Hoppe ER; Todisco G; Creignou M; Gallì A; Castellano CA; McConkey M; Tarun A; Wong W; Schenone M; Stanclift C; Tanenbaum B; Malolepsza E; Nilsson B; Bick AG; Weinstock JS; Miller M; Niroula A; Dunford A; Taylor-Weiner A; Wood T; Barbera A; Anand S; Psaty BM; Desai P; Cho MH; Johnson AD; Loos R; ; MacArthur DG; Lek M; ; Neuberg DS; Lage K; Carr SA; Hellstrom-Lindberg E; Malcovati L; Papaemmanuil E; Stewart C; Getz G; Bradley RK; Jaiswal S; Ebert BL
Blood Cancer Discov; 2021 Sep; 2(5):500-517. PubMed ID: 34568833
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization, intragenic tandem duplication, and expression analysis of chicken TGFBR2 gene.
Ning B; Huang J; Xu H; Lou Y; Wang W; Mu F; Yan X; Li H; Wang N
Poult Sci; 2022 Dec; 101(12):102169. PubMed ID: 36201879
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
[TBL] [Abstract][Full Text] [Related]
9. Anti-TGF-beta strategies for the treatment of chronic liver disease.
Breitkopf K; Haas S; Wiercinska E; Singer MV; Dooley S
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):121S-131S. PubMed ID: 16344596
[TBL] [Abstract][Full Text] [Related]
10. A Novel Splice Variant of Human TGF-β Type II Receptor Encodes a Soluble Protein and Its Fc-Tagged Version Prevents Liver Fibrosis
Bertolio MS; La Colla A; Carrea A; Romo A; Canziani G; Echarte SM; Campisano S; Barletta GP; Monzon AM; Rodríguez TM; Chisari AN; Dewey RA
Front Cell Dev Biol; 2021; 9():690397. PubMed ID: 34568316
[TBL] [Abstract][Full Text] [Related]
11. Chimeric TβRII-SE/Fc overexpression by a lentiviral vector exerts strong antitumoral activity on colorectal cancer-derived cell lines in vitro and on xenografts.
Romo A; Rodríguez TM; Yu G; Dewey RA
Cancer Gene Ther; 2024 Jan; 31(1):174-185. PubMed ID: 37993543
[TBL] [Abstract][Full Text] [Related]
12. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
13. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
